CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

Abbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD ...

Abbott and MSD Pharmaceuticals announced a distribution pact for oral anti-diabetic medicines like Januvia, Janumet, and ...

Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...

Abbott and MSD Pharmaceuticals announced a partnership to distribute oral anti-diabetic medicines, specifically sitagliptin, ...

Abbott & MSD ink strategic pact to distribute innovative oral anti-diabetic medicines in India: Our Bureau, Bengaluru Thursday, June 19, 2025, 12:30 Hrs [IST] Abbott and MSD Pharm ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Abbott partners with MSD to distribute leading diabetes medications in India, enhancing patient access and care.

Under the terms of the partnership, Abbott will utilise its distribution infrastructure to promote MSD’s sitagliptin-based ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data ...

Research symposia focus on new combinations and medication formulations for both obesity and type 2 diabetes, as well as new ...

Medtronic, a global leader in healthcare technology, will present data at the American Diabetes Association (ADA) 85th ...